As of June 2023 10x Genomics has a market cap of $6.41 Billion. This makes 10x Genomics the world's 2057th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $6.41 B | 53.74% |
2022 | $4.17 B | -74.93% |
2021 | $16.63 B | 9.21% |
2020 | $15.23 B | 107.63% |
2019 | $7.33 B |
On Jun 8th, 2023 the market cap of 10x Genomics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $15.16 M | -99.76% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $91.57 M | -98.57% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $0.66 B | -89.65% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $4.83 B | -24.64% | Jersey |